96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort study
2025 · Journal of Global Antimicrobial Resistance · 0 citations
https://doi.org/10.1016/j.jgar.2025.10.002